C-reactive protein (CRP) is a well-established acute-phase reactant produced by the liver in response to inflammation, primarily driven by interleukin-6. Chronically elevated CRP levels (≥3 mg/L) are associated with various conditions including cardiovascular disease, metabolic syndrome, and autoimmune disorders. The link between CRP-related inflammation and fatigue is mechanistically plausible: pro-inflammatory cytokines can cross the blood-brain barrier and induce 'sickness behavior'—a set of symptoms including lethargy, fatigue, and cognitive impairment. Observational studies consistently show higher CRP levels in individuals reporting chronic fatigue, even after adjusting for comorbidities. However, the evidence is largely associative (human-observational), not definitively causal. Fatigue is multifactorial; CRP alone cannot diagnose its cause. A single elevated CRP value does not prove that inflammation is driving the fatigue—it could be a bystander or reflect an underlying condition. Clinical interpretation requires considering lifestyle factors (sleep, stress, diet), other lab markers, and symptoms. In practice, CRP is a useful screening tool for inflammation, but not a standalone fatigue biomarker. For persistent fatigue with elevated CRP, a thorough medical workup is recommended to identify treatable causes such as infection, autoimmune disease, or chronic inflammatory conditions.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-014f52ff69d67decff091c78